These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33764261)

  • 21. Preclinical and clinical development of the oral multikinase inhibitor sorafenib in cancer treatment.
    Strumberg D
    Drugs Today (Barc); 2005 Dec; 41(12):773-84. PubMed ID: 16474853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma.
    Upton ML; Tangner CH; Payton ME
    J Am Vet Med Assoc; 2006 Feb; 228(4):549-52. PubMed ID: 16478428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial urinary tract infections associated with transitional cell carcinoma in dogs.
    Budreckis DM; Byrne BA; Pollard RE; Rebhun RB; Rodriguez CO; Skorupski KA
    J Vet Intern Med; 2015; 29(3):828-33. PubMed ID: 25940672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.
    Mancuso A; Di Paola ED; Leone A; Catalano A; Calabrò F; Cerbone L; Zivi A; Messina C; Alonso S; Vigna L; Caristo R; Sternberg CN
    BJU Int; 2012 Jan; 109(2):200-6. PubMed ID: 22212284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-Raf
    Sun S; He Z; Huang M; Wang N; He Z; Kong X; Yao J
    Bioorg Med Chem; 2018 May; 26(9):2381-2391. PubMed ID: 29631788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A significant response to sorafenib in a woman with advanced lung adenocarcinoma and a BRAF non-V600 mutation.
    Sereno M; Moreno V; Moreno Rubio J; Gómez-Raposo C; García Sánchez S; Hernández Jusdado R; Falagan S; Zambrana Tébar F; Casado Sáenz E
    Anticancer Drugs; 2015 Oct; 26(9):1004-7. PubMed ID: 26237499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of receptor tyrosine kinase targets PDGFR-β, VEGFR2 and KIT in canine transitional cell carcinoma.
    Walters L; Martin O; Price J; Sula MM
    Vet Comp Oncol; 2018 Mar; 16(1):E117-E122. PubMed ID: 28884928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transitional cell carcinoma of the urethra metastatic to the eyes in a dog.
    Szymanski C; Boyce R; Wyman M
    J Am Vet Med Assoc; 1984 Nov; 185(9):1003-4. PubMed ID: 6511631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutaneous metastasis of transitional cell carcinoma in 12 dogs.
    Reed LT; Knapp DW; Miller MA
    Vet Pathol; 2013 Jul; 50(4):676-81. PubMed ID: 23136183
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
    Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
    Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BRAF mutation status and its prognostic significance in 79 canine urothelial carcinomas: A retrospective study (2006-2019).
    Gedon J; Kehl A; Aupperle-Lellbach H; von Bomhard W; Schmidt JM
    Vet Comp Oncol; 2022 Jun; 20(2):449-457. PubMed ID: 34878687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-tumour effect of lapatinib in canine transitional cell carcinoma cell lines.
    Sakai K; Maeda S; Saeki K; Nakagawa T; Murakami M; Endo Y; Yonezawa T; Kadosawa T; Mori T; Nishimura R; Matsuki N
    Vet Comp Oncol; 2018 Dec; 16(4):642-649. PubMed ID: 30246405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Total cystectomy for treatment of transitional cell carcinoma of the urethra and bladder trigone in a dog.
    Boston S; Singh A
    Vet Surg; 2014 Mar; 43(3):294-300. PubMed ID: 24433358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Scirrhous transitional cell carcinoma of the canine urethra.
    Sadowski PM; Lumsden JH
    Can Vet J; 1973 Jul; 14(7):159-61. PubMed ID: 4727321
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of microsatellite instability in urine for the diagnosis of transitional cell carcinoma of the lower urinary tract in dogs.
    Sotirakopoulos AJ; Armstrong PJ; Heath L; Madrill NJ; McNiel EA
    J Vet Intern Med; 2010; 24(6):1445-51. PubMed ID: 21039871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transitional cell carcinomas of the urinary tract in a colony of beagle dogs.
    Nikula KJ; Benjamin SA; Angleton GM; Lee AC
    Vet Pathol; 1989 Nov; 26(6):455-61. PubMed ID: 2603326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of transitional cell carcinoma of the urinary bladder in dogs: a review.
    Fulkerson CM; Knapp DW
    Vet J; 2015 Aug; 205(2):217-25. PubMed ID: 25747698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine transitional cell carcinoma.
    Mutsaers AJ; Widmer WR; Knapp DW
    J Vet Intern Med; 2003; 17(2):136-44. PubMed ID: 12683611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of six canine prostate adenocarcinoma and three transitional cell carcinoma cell lines derived from primary tumor tissues as well as metastasis.
    Packeiser EM; Hewicker-Trautwein M; Thiemeyer H; Mohr A; Junginger J; Schille JT; Murua Escobar H; Nolte I
    PLoS One; 2020; 15(3):e0230272. PubMed ID: 32168360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Treatment of Metastatic Upper Tract Urothelial Carcinoma With Vemurafenib: Case Report.
    Ji G; Qian Y
    Clin Genitourin Cancer; 2017 Aug; 15(4):e719-e721. PubMed ID: 28024948
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.